Meningioma and Embolism Thrombosis Risk & Investigation of Coagulation
NCT ID: NCT06709833
Last Updated: 2025-01-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
100 participants
OBSERVATIONAL
2024-12-16
2026-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
In this prospective observational trial, the investigators aim to evaluate the changes in coagulation and platelet function caused by tumor resection.
Blood samples are obtained by patients undergoing meningioma resection before and immediately after resection to detect said changes.
As a control cohort, blood samples are obtained from patients undergoing resection for glioma.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Surgical Resection of Latent Brain Tumors Prior to Recurrence
NCT04810871
The Roles of Tissue Factor in Malignant Gliomas
NCT00201903
Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients
NCT00985036
Cavernous Sinus Dissection and Bleeding in Meningiomas
NCT02863484
Prospective Cohort of Patients With Newly Diagnosed Glioblastoma: Analysis of MMP2 and MMP9 Expression and Correlation to Neuro-imaging Features.
NCT03526822
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Meningioma resection
patients undergoing resection for meningioma
No interventions assigned to this group
Glioma resection
Patients undergoing glioma resection as a control cohort for meningioma patients
No interventions assigned to this group
Healthy controls
Healthy controls without tumor and surgical resection
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients undergoing resection for glioma or
* Healthy controls
* written consent for study participation
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Tuebingen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University Hospital for Anaesthesiology and Intensive Care Medicine, Tuebingen
Tübingen, Baden-Wurttemberg, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
001_2024_BO2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.